MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 04-18-2026
Insulet Corporation DPO Ratio 2011-2026 | PODD
Annual DPO Ratio Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.5 | 11.4 | 17 | - | 48.3 | 61.5 | 56.6 | 47.1 | 36.7 | 30.8 | 38.7 | 36.8 | 52.5 | 28.7 | 48.7 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.5 | 11.4 | 38.4 |
Quarterly DPO Ratio Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.6 | 35.6 | - | - | 32 | 44.2 | - | - | - | - | - | - | - | - | 47.9 | - | 56.3 | 61.4 | 60.9 | - | 51.4 | 39.2 | 58.3 | - | 72.1 | 81.9 | 69 | - | 47.4 | 55.1 | 47.7 | - | 46.3 | 49.4 | 40.5 | - | 30.6 | 32.6 | 34.8 | - | 34.9 | 46.2 | 66.9 | - | 36.2 | 36.9 | 42.7 | - | 52.4 | 53.1 | 40.7 | - | 28.1 | 29.8 | 34.5 | - | 40 | 59 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 81.9 | 28.1 | 46.7 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Electromed
ELMD
|
47.8 | $ 25.3 | 0.8 % | $ 214 M |  USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.0 | 0.76 % | $ 1.22 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
IRIDEX Corporation
IRIX
|
71.9 | $ 1.04 | 0.72 % | $ 17.6 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 12.96 | -0.84 % | $ 1.75 B | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 14.75 | 0.75 % | $ 346 M | USA |
 |
LivaNova PLC
LIVN
|
68 | $ 58.86 | -0.1 % | $ 3.21 B |  Britain |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.35 | 1.06 % | $ 125 M |  France |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
PAVmed
PAVM
|
1.12 K | $ 8.54 | -4.32 % | $ 5.73 M | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 10.44 | 0.97 % | $ 296 M | USA |
 |
Sintx Technologies
SINT
|
223 | $ 2.07 | 4.02 % | $ 5.74 M | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
107 | $ 0.63 | -1.29 % | $ 39.2 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Stryker Corporation
SYK
|
70.1 | $ 316.51 | 0.49 % | $ 121 B | USA |
 |
Tactile Systems Technology
TCMD
|
24.4 | $ 22.36 | -0.62 % | $ 511 M | USA |
 |
TELA Bio
TELA
|
31.8 | $ 0.94 | 9.29 % | $ 44.1 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Tandem Diabetes Care
TNDM
|
35.7 | $ 18.53 | 2.04 % | $ 1.26 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Varex Imaging Corporation
VREX
|
42.5 | $ 11.38 | 3.13 % | $ 471 M | USA |
 |
Vivos Therapeutics
VVOS
|
73.4 | $ 0.83 | 6.36 % | $ 8.53 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.55 | -7.52 % | $ 963 M | USA |
 |
Second Sight Medical Products
EYES
|
29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Globus Medical
GMED
|
33.1 | $ 88.88 | 1.24 % | $ 12 B | USA |
 |
Delcath Systems
DCTH
|
56 | $ 10.28 | 0.69 % | $ 368 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 37.15 | 3.31 % | $ 1.15 B | USA |
 |
Inspire Medical Systems
INSP
|
103 | $ 53.58 | 0.32 % | $ 1.57 B | USA |
 |
Integer Holdings Corporation
ITGR
|
28.9 | $ 85.0 | 1.59 % | $ 2.95 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
58.1 | $ 81.56 | 0.43 % | $ 47.7 B | USA |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |